Literature DB >> 6406779

Convulsions induced by submaximal dose of pentylenetetrazol in mice are antagonized by the benzodiazepine antagonist Ro 15-1788.

G Grecksch, L P de Carvalho, P Venault, G Chapouthier, J Rossier.   

Abstract

The effects of benzodiazepine antagonist Ro 15-1788, alone or with diazepam, were studied in mice on convulsions induced by pentylenetetrazol (PTZ). We found that Ro 15-1788 (1 mg/kg) was able to antagonize the anticonvulsive effects of diazepam (1 mg/kg), but also had, with submaximal doses of PTZ (65 mg/kg), its own anticonvulsive action. At very low doses (0.1 mg/kg), it even potentiated the anticonvulsive effects of diazepam (0.05 mg/kg). This dual action provides evidence for partial agonist properties of the antagonist Ro 15-1788.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6406779     DOI: 10.1016/0024-3205(83)90241-2

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  14 in total

1.  The effects of the benzodiazepine antagonist Ro 15-1788 on psychophysiological performance and subjective measures in normal subjects.

Authors:  A Higgitt; M Lader; P Fonagy
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

Review 2.  Intrinsic actions of the benzodiazepine receptor antagonist Ro 15-1788.

Authors:  S E File; S Pellow
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

Review 3.  Multiple sites of action for anxiogenic drugs: behavioural, electrophysiological and biochemical correlations.

Authors:  S Pellow; S E File
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

4.  Bidirectional effects of benzodiazepine receptor ligands against picrotoxin- and pentylenetetrazol-induced seizures.

Authors:  L H Jensen; E N Petersen
Journal:  J Neural Transm       Date:  1983       Impact factor: 3.575

5.  Evaluation of visual function in healthy subjects after administration of Ro 15-1788.

Authors:  Y Lupolover; A B Safran; D Desangles; C de Weisse; J J Meyer; A Bousquet; A Assimacopoulos
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

6.  The affinities, potencies and efficacies of some benzodiazepine-receptor agonists, antagonists and inverse-agonists at rat hippocampal GABAA-receptors.

Authors:  J A Kemp; G R Marshall; E H Wong; G N Woodruff
Journal:  Br J Pharmacol       Date:  1987-07       Impact factor: 8.739

7.  A mouse mutant strain highly resistant to methyl beta-carboline-3-carboxylate-induced seizures.

Authors:  Y Clément; J M Launay; D Bondoux; P Venault; B Martin; J Young; P Robel; G Chapouthier
Journal:  Exp Brain Res       Date:  1996-06       Impact factor: 1.972

8.  L-lysine is a barbiturate-like anticonvulsant and modulator of the benzodiazepine receptor.

Authors:  Y F Chang; X M Gao
Journal:  Neurochem Res       Date:  1995-08       Impact factor: 3.996

Review 9.  Flumazenil. A preliminary review of its benzodiazepine antagonist properties, intrinsic activity and therapeutic use.

Authors:  R N Brogden; K L Goa
Journal:  Drugs       Date:  1988-04       Impact factor: 9.546

10.  Pharmacological alterations of anxious behaviour in mice depending on both strain and the behavioural situation.

Authors:  Yan Clément; Anne-Marie Le Guisquet; Patrice Venault; Georges Chapouthier; Catherine Belzung
Journal:  PLoS One       Date:  2009-11-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.